Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Insulet Corp
(NQ:
PODD
)
229.94
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Insulet Corp
< Previous
1
2
3
4
5
6
7
8
9
Next >
Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout.
October 02, 2024
Why INSULET CORP (NASDAQ:PODD) Is a Promising High-Growth Stock in the Midst of Consolidation.
Via
Chartmill
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
September 24, 2024
Via
Benzinga
Analyst Expectations For Insulet's Future
September 17, 2024
Via
Benzinga
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
September 17, 2024
Via
Benzinga
Upstart, Insulet And 2 Other Stocks Executives Are Selling
September 12, 2024
Via
Benzinga
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
September 10, 2024
Via
Benzinga
(PODD) - Analyzing Insulet's Short Interest
August 30, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
August 28, 2024
Via
Benzinga
The Latest Analyst Ratings For Insulet
August 12, 2024
Via
Benzinga
Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
September 02, 2024
Top-performing large-cap stocks from last week: AFRM, NTNX, MDB, BBY, GEV, TCOM, COO, PODD, VEEV, AZPN.
Via
Benzinga
Why Insulet Stock Was Zooming Higher This Week
August 30, 2024
The company had encouraging news to impart about its leading insulin pump.
Via
The Motley Fool
Stocks To Watch Today: PODD, SMCI, And PAYC
August 27, 2024
Insulet Corporation surged on FDA approval for its diabetes treatment device, while SMCI faced pressure from a short-seller report, and Paycom Software saw insider selling activity.
Via
Talk Markets
Exposures
Product Safety
S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
August 20, 2024
S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Peering Into Insulet's Recent Short Interest
August 12, 2024
Via
Benzinga
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
August 08, 2024
INSULET CORP (NASDAQ:PODD)—A High-Growth Stock Gearing Up for Its Next Upward Move.
Via
Chartmill
Here's How Much $100 Invested In Insulet 10 Years Ago Would Be Worth Today
August 07, 2024
Via
Benzinga
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
August 09, 2024
After a blistering Thursday that saw the S&P 500 close with its best session in nearly two years — up 2.3% — Wall Street’s price action turned sluggish on a Friday lacking market-moving economic...
Via
Benzinga
Stocks On Track For Weekly Losses Despite Midday Gains
August 09, 2024
The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are attempting to pare this morning's losses as they move into positive territory for the afternoon.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst
August 09, 2024
Insulet reported a Q2 adjusted EPS of $0.55, slightly missing estimates but showing strong sales growth of 23.2% year-over-year, driven by Omnipod revenue. The company raised its 2024 revenue guidance,...
Via
Benzinga
A Closer Look at 7 Analyst Recommendations For Insulet
July 23, 2024
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $26,000 Today
July 19, 2024
Via
Benzinga
Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout.
July 17, 2024
Why INSULET CORP (NASDAQ:PODD) Is a Standout High-Growth Stock in a Consolidation Phase.
Via
Chartmill
PODD Stock Earnings: Insulet Misses EPS, Beats Revenue for Q2 2024
August 08, 2024
PODD stock results show that Insulet missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
August 08, 2024
Investor risk sentiment is showing greater conviction on Thursday, with all indices and major stock sectors in the green, after Wall Street failed to hold onto opening gains and closed in the red the...
Via
Benzinga
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
July 10, 2024
Via
Benzinga
(PODD) - Analyzing Insulet's Short Interest
July 05, 2024
Via
Benzinga
Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation.
June 26, 2024
INSULET CORP (NASDAQ:PODD), a strong growth stock, setting up for a breakout.
Via
Chartmill
Wall Street Set For Uneventful Start Ahead Of Jobless Claim Data, VIX Rises: Strategist Says Market May Remain Vulnerable Until...
August 08, 2024
U.S. stocks are set for a mixed start on Thursday as concerns regarding the economy and incremental yen carry trade unwinding remain an undercurrent. Traders may be keen to receive the jobless claims...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
Chips, Glorious Chips!
August 07, 2024
Someone's gotta make 'em, and someone's gotta buy 'em.
Via
The Motley Fool
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
July 26, 2024
Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.